Small Molecules

18 Sep 2007 Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
18 Sep 2007 Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
18 Sep 2007 Hollis-Eden Pharmaceuticals Announces Filing of IND for Phase I/II Clinical Trials with HE3286 in Diseases of Inflammation
18 Sep 2007 Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan
18 Sep 2007 Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
18 Sep 2007 Idera Pharmaceuticals Initiates Phase 1 Trial of IMO-2125 in Hepatitis C
18 Sep 2007 Sciele Pharma Completes Patient Enrollment for Pivotal Phase III Safety Trial for Glycopyrrolate
18 Sep 2007 Ligand Announces Positive Preclinical Data on Selective Androgen Receptor Modulator LGD-3303
18 Sep 2007 FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
18 Sep 2007 Metabasis Therapeutics Presents Promising Preclinical Results with Its Novel Glucagon Antagonist for the Treatment of Type 2 Diabetes
18 Sep 2007 NeuroSearch announces breakthrough tesofensine results from clinical Phase IIb study in obesity ("TIPO-1")
15 Sep 2007 FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
15 Sep 2007 Basilea Announces Positive Top-line Data from Phase III Study of Ceftobiprole in Community-acquired Pneumonia Requiring Hospitalization
15 Sep 2007 FDA approves SOMA 250 mg
15 Sep 2007 FDA Accepts NDA Filing for Cleviprex(TM) (Clevidipine Butyrate Injectable Emulsion) for the Treatment of Acute Hypertension
14 Sep 2007 Lipsovir(R) - All Patients in the Phase III Program Now Enrolled
14 Sep 2007 Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
14 Sep 2007 FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
14 Sep 2007 Critical Therapeutics Announces Publication of Results from Two Asthma Studies
14 Sep 2007 AlphaRx Announces Selection of ARX828, a Novel iNOS inhibitor, for Advanced Preclinical Development
14 Sep 2007 Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
14 Sep 2007 Cytopia's FMS inhibitor prevents bone loss in animals
13 Sep 2007 Hollis-Eden Pharmaceuticals Reports on Anti-Inflammatory Activity with HE3286 in Models of Diseases of Inflammation
13 Sep 2007 Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkin's Lymphoma (NHL)
13 Sep 2007 Cortex Files AMPAKINE CX717 IND for ADHD

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up